Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2Adenomatous Polyposis Coli 2Rectal Neoplasms 1Lymphoma, Mantle-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Duodenal Neoplasms 1Attenuated familial adenomatous polyposis 1

Interventions

Capecitabine 42Oxaliplatin 39Fluorouracil 29Leucovorin 23Radiotherapy 22Cetuximab 15Bevacizumab 15Irinotecan 13Nivolumab 12Magnetic Resonance Spectroscopy 11Specimen Handling 9Drug Therapy 9Surgical Procedures, Operative 8Folfox protocol 8pembrolizumab 7Radiotherapy, Intensity-Modulated 7Chemoradiotherapy 7Biopsy 7trifluridine tipiracil drug combination 6Radiation 6tislelizumab 5sintilimab 5regorafenib 5dehydroftorafur 5X-Rays 5Surveys and Questionnaires 5Sigmoidoscopy 5Endoscopy 5Consolidation Chemotherapy 5spartalizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Endoscopy, Gastrointestinal × 1 year × Clear all
NCT06834126 2025-07-18

Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial

City of Hope Medical Center

Phase 1 Recruiting
36 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡